Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11.

Abstract:

:Inversion of chromosome 16 is a consistent finding in patients with acute myeloid leukemia subtype M4 with eosinophilia, which generates a CBFB-MYH11 fusion gene. Previous studies showed that the interaction between CBFβ-smooth muscle myosin heavy chain (SMMHC; encoded by CBFB-MYH11) and RUNX1 plays a critical role in the pathogenesis of this leukemia. Recently, it was shown that chromodomain helicase DNA-binding protein-7 (CHD7) interacts with RUNX1 and suppresses RUNX1-induced expansion of hematopoietic stem and progenitor cells. These results suggest that CHD7 is also critical for CBFB-MYH11-induced leukemogenesis. To test this hypothesis, we generated Chd7f/fMx1-CreCbfb+/56M mice, which expressed the Cbfb-MYH11 fusion gene and deactivated Chd7 in hematopoietic cells upon inducing Cre with polyinosinic-polycytidylic acid. The Lin-Sca1-c-Kit+ (LK) population was significantly lower in Chd7f/fMx1-CreCbfb+/56M mice than in Mx1-CreCbfb+/56M mice. In addition, there were fewer 5-bromo-2'-deoxyuridine-positive cells in the LK population in Chd7f/fMx1-CreCbfb+/56M mice, and genes associated with cell cycle, cell growth, and proliferation were differentially expressed between Chd7f/fMx1-CreCbfb+/56M and Mx1-CreCbfb+/56M leukemic cells. In vitro studies showed that CHD7 interacted with CBFβ-SMMHC through RUNX1 and that CHD7 enhanced transcriptional activity of RUNX1 and CBFβ-SMMHC on Csf1r, a RUNX1 target gene. Moreover, RNA sequencing of c-Kit+ cells showed that CHD7 functions mostly through altering the expression of RUNX1 target genes. Most importantly, Chd7 deficiency delayed Cbfb-MYH11-induced leukemia in both primary and transplanted mice. These data indicate that Chd7 is important for Cbfb-MYH11-induced leukemogenesis by facilitating RUNX1 regulation of transcription and cellular proliferation.

journal_name

Blood

journal_title

Blood

authors

Zhen T,Kwon EM,Zhao L,Hsu J,Hyde RK,Lu Y,Alemu L,Speck NA,Liu PP

doi

10.1182/blood-2017-04-780106

subject

Has Abstract

pub_date

2017-11-30 00:00:00

pages

2431-2442

issue

22

eissn

0006-4971

issn

1528-0020

pii

blood-2017-04-780106

journal_volume

130

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Infectious mononucleosis: sequential immunologic, cytochemical, and cytokinetic studies on single lymphoid cells in peripheral blood.

    abstract::Sequential immunologic, cytochemical, and cytokinetic studies were done on single lymphoid cells in the peripheral blood of 6 children with infectious mononucleosis (IM) and 1 child with toxoplasmosis 1-2 wk after onset of symptomatology. The absolute number of AET-SRBC rosetting (E+) cells was increased in all patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hirt A,Imbach P,Morell A,Wagner HP

    更新日期:1981-09-01 00:00:00

  • Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men.

    abstract::We investigated the effects of granulocyte colony-stimulating factor (G-CSF) on cytokine and cytokine receptor plasma levels and on the in vivo host response to Salmonella abortus equi endotoxin in healthy males. Twenty volunteers received 0.8 ng/kg endotoxin and saline intravenously 1 week apart in randomized order. ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Pollmächer T,Korth C,Mullington J,Schreiber W,Sauer J,Vedder H,Galanos C,Holsboer F

    更新日期:1996-02-01 00:00:00

  • Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia.

    abstract::Hematopoietic function of some aplastic anemia (AA) patients is dependent on the administration of cyclosporine (CyA). To investigate whether certain HLA class II genes are associated with susceptibility to such CyA-dependent AA, we determined the HLA class II alleles of 59 AA patients treated with CyA. Among 26 patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nakao S,Takamatsu H,Chuhjo T,Ueda M,Shiobara S,Matsuda T,Kaneshige T,Mizoguchi H

    更新日期:1994-12-15 00:00:00

  • Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia.

    abstract::Microsatellite instability (MSI) and p53 mutations have been reported to occur in a significant proportion of patients with therapy-related acute myeloid leukemia (AML). MSH2 is one of the genes involved in DNA mismatch repair to maintain fidelity of genomic replication, and defects of MSH2 are directly involved in MS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zhu YM,Das-Gupta EP,Russell NH

    更新日期:1999-07-15 00:00:00

  • Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells.

    abstract::The endosteal niche is critical for the maintenance of hematopoietic stem cells (HSCs). However, it consists of a heterogeneous population in terms of differentiation stage and function. In this study, we characterized endosteal cell populations and examined their ability to maintain HSCs. Bone marrow endosteal cells ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-239194

    authors: Nakamura Y,Arai F,Iwasaki H,Hosokawa K,Kobayashi I,Gomei Y,Matsumoto Y,Yoshihara H,Suda T

    更新日期:2010-09-02 00:00:00

  • Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.

    abstract::Collagen binding to glycoprotein VI (GPVI) induces signals critical for platelet activation in thrombosis. Both ligand-induced GPVI signaling through its coassociated Fc-receptor gamma-chain (FcRgamma) immunoreceptor tyrosine-activation motif (ITAM) and the calmodulin inhibitor, W7, dissociate calmodulin from GPVI and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-086983

    authors: Gardiner EE,Karunakaran D,Arthur JF,Mu FT,Powell MS,Baker RI,Hogarth PM,Kahn ML,Andrews RK,Berndt MC

    更新日期:2008-01-01 00:00:00

  • VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

    abstract::In human follicular lymphoma the t(14; 18) chromosome translocation activates the antiapoptotic oncogene Bcl2 by linking it to the immunoglobulin heavy chain (IGH) locus. Transgenic mice expressing Bcl2 controlled by an Igh enhancer (E mu) do not develop follicular lymphoma, although they do have an increased incidenc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2469

    authors: Egle A,Harris AW,Bath ML,O'Reilly L,Cory S

    更新日期:2004-03-15 00:00:00

  • Genetic evidence for an additional factor required for erythropoietin-induced signal transduction.

    abstract::Erythropoietin (EPO) and its receptor (EPOR) are required for the development of mature erythrocytes. After binding of ligand, the EPOR activates a variety of signaling pathways that ultimately control cellular proliferation, survival, and specific gene expression. Although erythroid progenitors appear to be the princ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gaffen SL,Lai SY,Longmore GD,Liu KD,Goldsmith MA

    更新日期:1999-07-01 00:00:00

  • Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation.

    abstract::T-cell function directly influences several B-cell functions. The effect of T-cell subgroups on B-cell function (DNA synthesis) was evaluated for controls and patients with B-cell type of CLL. Control and CLL intact T cells, T cells with receptors for IgG (T gamma), and T cells without Fc receptors at isolation (T non...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kay NE

    更新日期:1981-03-01 00:00:00

  • Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.

    abstract::Protein tyrosine phosphorylation plays a crucial role in signaling from the receptor for erythropoietin (Epo), although the Epo receptor (EpoR) lacks the tyrosine kinase domain. We have previously shown that the Jak2 tyrosine kinase couples with the EpoR to transduce a growth signal. In the present study, we demonstra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chin H,Arai A,Wakao H,Kamiyama R,Miyasaka N,Miura O

    更新日期:1998-05-15 00:00:00

  • Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences.

    abstract::Plasmin exposure modulates platelet aggregation responses, but a direct effect of plasmin on the platelet fibrinogen receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), has never been conclusively shown in a plasma milieu. To examine this issue, we incubated platelets in platelet-rich plasma with plasmin and measured the ef...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pasche B,Ouimet H,Francis S,Loscalzo J

    更新日期:1994-01-15 00:00:00

  • One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stress.

    abstract::In systemic light-chain amyloidosis, λ light chains produced by clonal plasma cells cause organ damage and early death. In pursuit of novel therapy, we developed 1 pool of short interfering RNA (siRNA) targeting the constant region of λ light chains that substantially and promptly reduces λ-light-chain production and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-535187

    authors: Zhou P,Ma X,Iyer L,Chaulagain C,Comenzo RL

    更新日期:2014-05-29 00:00:00

  • How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns.

    abstract::Insights into immune-mediated thrombotic thrombocytopenic purpura (iTTP) pathophysiology have led to novel targeted therapies. Immunomodulatory strategies target anti-ADAMTS13 antibodies: rituximab is effective in inducing responses in refractory/relapsed TTP and increasing relapse-free survival; caplacizumab targets ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.2019000954

    authors: Mazepa MA,Masias C,Chaturvedi S

    更新日期:2019-08-01 00:00:00

  • Minimal residual disease is an independent predictor for 10-year survival in CLL.

    abstract::Minimal residual disease (MRD) negativity, defined as <1 chronic lymphocytic leukemia (CLL) cell detectable per 10 000 leukocytes, has been shown to independently predict for clinical outcome in patients receiving combination chemoimmunotherapy in the frontline setting. However, the long-term prognostic value of MRD s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-05-714162

    authors: Kwok M,Rawstron AC,Varghese A,Evans PA,O'Connor SJ,Doughty C,Newton DJ,Moreton P,Hillmen P

    更新日期:2016-12-15 00:00:00

  • CXCR4 is a prognostic marker in acute myelogenous leukemia.

    abstract::CXCR4 chemokine receptors retain hematopoietic progenitors and leukemia cells within the marrow microenvironment. We prospectively evaluated the prognostic implication of CXCR4 in 90 consecutive patients with acute myelogenous leukemia (AML) by flow cytometry. Patients were divided into groups with low (n=32), interme...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-024844

    authors: Spoo AC,Lübbert M,Wierda WG,Burger JA

    更新日期:2007-01-15 00:00:00

  • Restoration of superoxide generation to a chronic granulomatous disease-derived B-cell line by retrovirus mediated gene transfer.

    abstract::Failure of a superoxide generating system, the NADPH oxidase, present in neutrophils and other phagocytes gives rise to chronic granulomatous disease (CGD), a group of single-gene inherited disorders all characterized by an extreme susceptibility to pyogenic infection, with potentially fatal consequences. About 30% of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Thrasher A,Chetty M,Casimir C,Segal AW

    更新日期:1992-09-01 00:00:00

  • Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells.

    abstract::Leukemia inhibitory factor (LIF)/differentiation-inhibiting activity (DIA)/human interleukin for DA cells (HILDA) is a cytokine with biologic activities involving a variety of different types of target cells. Here we have tested LIF/DIA for possible effects on the growth and differentiation of normal human hematopoiet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Leary AG,Wong GG,Clark SC,Smith AG,Ogawa M

    更新日期:1990-05-15 00:00:00

  • A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

    abstract::Although bispecific antibodies directed against malignant lymphoma have been shown to be effective in vitro and in vivo, extended clinical trials so far have been hampered by the fact that conventional approaches to produce these antibodies suffer from low yields, ill-defined byproducts, or laborious purification proc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Löffler A,Kufer P,Lutterbüse R,Zettl F,Daniel PT,Schwenkenbecher JM,Riethmüller G,Dörken B,Bargou RC

    更新日期:2000-03-15 00:00:00

  • Metnase mediates chromosome decatenation in acute leukemia cells.

    abstract::After DNA replication, sister chromatids must be untangled, or decatenated, before mitosis so that chromatids do not tear during anaphase. Topoisomerase IIalpha (Topo IIalpha) is the major decatenating enzyme. Topo IIalpha inhibitors prevent decatenation, causing cells to arrest during mitosis. Here we report that acu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-175760

    authors: Wray J,Williamson EA,Sheema S,Lee SH,Libby E,Willman CL,Nickoloff JA,Hromas R

    更新日期:2009-08-27 00:00:00

  • IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and {gamma}{delta} T cells in vivo.

    abstract::Homeostatic mechanism by which peripheral T-cell subsets are maintained in vivo remains largely unknown. Using a T-cell proliferation model under lymphopenic settings, we now demonstrate that gammadelta T cells limit CD8 T-cell expansion but not the initial proliferation after transfer into lymphopenic recipients. Int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-192997

    authors: Do JS,Min B

    更新日期:2009-06-18 00:00:00

  • The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia.

    abstract::In patients with chronic lymphocytic leukemia (CLL), lenalidomide can promote humoral immune responses but also induces a distinct disease-specific toxicity of tumor flare and cytokine release. These CLL-specific events result from increased expression of costimulatory molecules on B cells. Here we demonstrate that le...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-315705

    authors: Herman SE,Lapalombella R,Gordon AL,Ramanunni A,Blum KA,Jones J,Zhang X,Lannutti BJ,Puri KD,Muthusamy N,Byrd JC,Johnson AJ

    更新日期:2011-04-21 00:00:00

  • Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.

    abstract::Evidence supporting the efficacy of in utero hematopoietic cell transplantation (IUHCT) in a valid large animal model is needed prior to clinical application. The objective of this study was to establish clinically relevant levels of hematopoietic chimerism in a canine model of maternal-to-fetal IUHCT. We first assess...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-11-537571

    authors: Vrecenak JD,Pearson EG,Santore MT,Todorow CA,Li H,Radu A,Bhatti T,Peranteau WH,Johnson MP,Flake AW

    更新日期:2014-09-18 00:00:00

  • Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation.

    abstract::The W locus of mice encodes the c-kit receptor tyrosine kinase. Heterozygous WJic/+ and Wn/+ mice and homozygous Wf/Wf mice were similar in appearance; all of them have large depigmented areas lacking any well-defined pattern. The WJic, Wn, and Wf mutant alleles were characterized and their molecular nature was correl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tsujimura T,Koshimizu U,Katoh H,Isozaki K,Kanakura Y,Tono T,Adachi S,Kasugai T,Tei H,Nishimune Y

    更新日期:1993-05-15 00:00:00

  • Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.

    abstract::We report a transfusion trial of platelets photochemically treated for pathogen inactivation using the synthetic psoralen amotosalen HCl. Patients with thrombocytopenia were randomly assigned to receive either photochemically treated (PCT) or conventional (control) platelets for up to 28 days. The primary end point wa...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2003-12-4443

    authors: McCullough J,Vesole DH,Benjamin RJ,Slichter SJ,Pineda A,Snyder E,Stadtmauer EA,Lopez-Plaza I,Coutre S,Strauss RG,Goodnough LT,Fridey JL,Raife T,Cable R,Murphy S,Howard F 4th,Davis K,Lin JS,Metzel P,Corash L,Koutso

    更新日期:2004-09-01 00:00:00

  • Pre-TCR expression cooperates with TEL-JAK2 to transform immature thymocytes and induce T-cell leukemia.

    abstract::The TEL-JAK2 gene fusion, which has been identified in human leukemia, encodes a chimeric protein endowed with constitutive tyrosine kinase activity. TEL-JAK2 transgenic expression in the mouse lymphoid lineage results in fatal and rapid T-cell leukemia/lymphoma. In the present report we show that T-cell leukemic cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-048801

    authors: dos Santos NR,Rickman DS,de Reynies A,Cormier F,Williame M,Blanchard C,Stern MH,Ghysdael J

    更新日期:2007-05-01 00:00:00

  • Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.

    abstract::The transcription factor CCAAT enhancer binding protein α (C/EBPα) is a master regulator in granulopoiesis and is frequently disrupted in acute myeloid leukemia (AML). We have previously shown that C/EBPα exerts its effects by regulating microRNAs (miRs) such as miR-223 and miR-34a. Here, we confirm miR-30c as a novel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-472183

    authors: Katzerke C,Madan V,Gerloff D,Bräuer-Hartmann D,Hartmann JU,Wurm AA,Müller-Tidow C,Schnittger S,Tenen DG,Niederwieser D,Behre G

    更新日期:2013-10-03 00:00:00

  • Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation.

    abstract::Fourteen patients with cytogenetic relapse of chronic myeloid leukemia (CML) after transplantation with unmanipulated bone marrow were treated with alpha-2a-interferon. There were eight men and six women, median age, 33 years. Twelve patients received marrow from a related allogeneic donor and two received marrow from...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Higano CS,Chielens D,Raskind W,Bryant E,Flowers ME,Radich J,Clift R,Appelbaum F

    更新日期:1997-10-01 00:00:00

  • Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein.

    abstract::The novel human CC-chemokine Eotaxin is a potent and selective chemotaxin for eosinophils. Here, the biological activities and the activation profile of Eotaxin were further characterized and compared with those of other eosinophil chemotaxins such as complement fragment C5a (C5a), platelet-activating factor (PAF), an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tenscher K,Metzner B,Schöpf E,Norgauer J,Czech W

    更新日期:1996-10-15 00:00:00

  • An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures.

    abstract::Basic fibroblast growth factor (bFGF) is a hematopoietic cytokine that stimulates stromal and stem cell growth. It binds to a glycosylphosphatidylinositol (GPI)-anchored heparan sulfate proteoglycan on human bone marrow (BM) stromal cells. The bFGF-proteoglycan complex is biologically active and is released by additio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brunner G,Metz CN,Nguyen H,Gabrilove J,Patel SR,Davitz MA,Rifkin DB,Wilson EL

    更新日期:1994-04-15 00:00:00

  • Tumor vascular targeting therapy with viral vectors.

    abstract::Tumor angiogenesis is crucial for the progression and metastasis of cancer. The vasculature of tumor tissue is different from normal vasculature. Therefore, tumor vascular targeting therapy could represent an effective therapeutic strategy with which to suppress both primary tumor growth and tumor metastasis. The use ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2005-10-4114

    authors: Liu Y,Deisseroth A

    更新日期:2006-04-15 00:00:00